[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1993

Management of Scabies in Patients With Human Immunodeficiency Virus Disease

Author Affiliations

Craig Omohundro Department of Dermatology University of California San Francisco, CA 94143; Department of Dermatology, 4M70 San Francisco General Hospital 1001 Potrero Ave San Francisco, CA 94110

Arch Dermatol. 1993;129(7):911-913. doi:10.1001/archderm.1993.01680280101028
Abstract

To the Editor.—  A retrospective review of selected human immunodeficiency virus (HIV)-infected patients with scabies seen in our clinics between December 1990 and March 1992 revealed several clinical patterns with respect to morphologic findings and response to treatment. The Table lists representative cases with atypical clinical morphologic patterns or treatment responses. These patterns tended to correlate with helper T-cell count and the stage of HIV disease. Patients with CD4 counts above 1.5×109/L had normal clinical morphologic patterns. Atypical morphologic patterns were restricted to patients with CD4 counts less than 1.5×109/L. These included the following two different morphologic patterns:

  1. Papular scabies is defined as a diffuse uniform eruption of 5- to 7-mm papules, each topped with a scabietic burrow. Each lesion is erythematous and inflamed, but a diffuse hypersensitivity rash is not a component. There may be associated pruritus, sometimes severe.

  2. Norwegian scabies is defined as a generalized psoriasiform scaling and hyperkeratotic eruption. Thick, crusted plaques may be seen on the scalp, face, hands, buttocks, genitalia, and pressure-bearing areas. Pruritus may be slight to nonexistent.

First Page Preview View Large
First page PDF preview
First page PDF preview
×